Published within

|« « | 1 | » »|

Type Product title / description Pub Price

Type	Product title / description	Pub	Price
Report	Case Study: Sepsis - Xigris’ disappointing performance creates a market opportunity for improved sepsis therapies The Surviving Sepsis Campaign has created an increased focus on reducing levels of mortality from sepsis. Eli Lilly/BioCritica’s Xigris has been unable to capitalize on what remains a potentially lucrative therapy area with significant unmet needs. Published By Datamonitor	17 May 2011	$1520 Buy
Report	R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy Progress in sepsis drug development has been severely hindered by the complex disease pathogenesis and patient heterogeneity. This module reviews pipeline trends, clinical trial design, and future treatment paradigms for sepsis. Published By Datamonitor	06 Apr 2011	$2800 Buy
Report	Epidemiology: Sepsis – The incidence of severe sepsis is on the rise due to the dramatic aging populations across the developed world Overview of sepsis definition and a review of the epidemiology literature. This report provides in-depth analysis of patient populations, and 10-year incident case forecast, and key patient segments across the seven major markets. Published By Datamonitor	29 Mar 2011	$2800 Buy

Case Study: Sepsis - Xigris’ disappointing performance creates a market opportunity for improved sepsis therapies

The Surviving Sepsis Campaign has created an increased focus on reducing levels of mortality from sepsis. Eli Lilly/BioCritica’s Xigris has been unable to capitalize on what remains a potentially lucrative therapy area with significant unmet needs.

Published By Datamonitor

17 May 2011

$1520

Buy

Report

R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy

Progress in sepsis drug development has been severely hindered by the complex disease pathogenesis and patient heterogeneity. This module reviews pipeline trends, clinical trial design, and future treatment paradigms for sepsis.

Published By Datamonitor

06 Apr 2011

$2800

Buy

Report

Epidemiology: Sepsis – The incidence of severe sepsis is on the rise due to the dramatic aging populations across the developed world

Overview of sepsis definition and a review of the epidemiology literature. This report provides in-depth analysis of patient populations, and 10-year incident case forecast, and key patient segments across the seven major markets.

Published By Datamonitor

29 Mar 2011

$2800

Buy

|« « | 1 | » »|

Move
Close

Insight on Sepsis in Asia-Pacific

Select information type

Refine your search

Search tips

Case Study: Sepsis - Xigris’ disappointing performance creates a market opportunity for improved sepsis therapies

Published By Datamonitor

R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy

Published By Datamonitor

Epidemiology: Sepsis – The incidence of severe sepsis is on the rise due to the dramatic aging populations across the developed world

Published By Datamonitor

Help